3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
11
Triple Negative Breast Neoplasms
1
Osteoporosis
1
Neoplasm Metastasis
1
Joint Diseases
1
Breast Carcinoma In Situ
1
Bone Diseases, Metabolic
1
Interventions
Risedronic Acid
2
Zoledronic Acid
1
Kyphoplasty
1
Cholecalciferol
1
Aromatase Inhibitors
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Bone Diseases, Metabolic
×
Anastrozole
×
Clear all
NCT00082277
2011-01-26
SABRE
AstraZeneca
Phase 4
Completed
237 enrolled